Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.
第一作者:
D,Strumberg
第一单位:
Department of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen, Germany.
作者:
主题词
抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);抗肿瘤药(Antineoplastic Agents);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);乳腺肿瘤(Breast Neoplasms);卡莫司汀(Carmustine);顺铂(Cisplatin);环磷酰胺(Cyclophosphamide);DNA损伤(DNA Damage);多柔比星(Doxorubicin);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);人类(Humans);美法仑(Melphalan);氮芥化合物(Nitrogen Mustard Compounds);卵巢肿瘤(Ovarian Neoplasms);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1097/00001813-199606000-00007
PMID
8826610
发布时间
2019-09-14
- 浏览35

Anti-cancer drugs
415-21页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文